Tuberculosis: A Global Health Crisis Returns
Tuberculosis (TB) is once again the leading infectious disease killer worldwide, surpassing even COVID-19 deaths, according to a new World Health Organization (WHO) report. The alarming statistic comes as the global community strives to end TB by 2030.
Data collated from 193 countries reveals that TB claimed 1.25 million lives in 2023, significantly higher than the 320,000 deaths attributed to COVID-19 during the same period. A staggering 10.8 million individuals fell ill with TB last year, marking a slight increase from 2022’s figures. While this represents progress compared to the 1.42 million deaths in 2021, it remains a concerning trend.
Geographical Disparity:
A stark reality highlighted in the report is the unequal burden of TB. A majority of infections, 87 percent, occurred in just 30 countries. India, Indonesia, China, the Philippines, and Pakistan accounted for 56 percent of the global TB burden.
A Preventable and Treatable Disease:
Despite the grim statistics, the WHO emphasizes that TB is a preventable and curable disease. Around 85 percent of cases can be successfully treated. However, nearly 50 percent of individuals who fail to receive treatment succumb to the disease. This underscores the critical need for access to timely diagnosis and treatment.
“Tuberculosis is a preventable and usually curable disease,” states the WHO report. “Yet in 2023, TB probably returned to being the world’s leading cause of death from a single infectious agent, following 3 years in which it was replaced by coronavirus disease (COVID-19), and caused almost twice as many deaths as HIV/AIDS.”
Urgent Action Needed:
“Urgent action is required to end the global TB epidemic by 2030, a goal that has been adopted by all Member States of the United Nations (UN) and the World Health Organization,” write the authors. However, funding remains a significant obstacle. While six new vaccines are currently in Phase III clinical trials, offering hope for a new treatment within five years, investment in prevention, diagnostics, and treatment remains far short of targets. Only $5.7 billion was allocated for TB programs last year, compared to the WHO’s goal of $22 billion by 2027. Research funding, at $1 billion, is also significantly below the desired $5 billion annual target.
WHO Director-General Dr Tedros Adhanom Ghebreyesus emphasizes the urgency of the situation, stating, “The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it and treat it. WHO urges all countries to make good on the concrete commitments they have made to expand the use of those tools, and to end TB.”
**Take Action:** Learn more about tuberculosis and how you can contribute to ending this global epidemic. Visit the WHO website: https://www.who.int/news/item/29-10-2024-tuberculosis-resurges-as-top-infectious-disease-killer